Pharmacists To Face Music If Found Illegally Diverting Codeine-Based Cough Syrups

Mumbai : The pharmacists will face the music if they are selling Codeine-based cough syrups without valid prescription as the Narcotics Control Bureau (NCB) is probing its trafficking through children and terminally ill persons. Codeine is also an opiate and used in reducing pain. The medicine containing it can be bought against a prescription. NCB sources stated that such syrups are common among drug abusers as a bottle is available for Rs 150. “We will verify them if the investigation leads towards that angle,” said a high-ranking officer.

The agency which recently arrested peddlers revealed certain disturbing facts. The investigations have revealed that the cough syrup is abused by children in slums and terminally ill persons. The peddlers also encourage them to further peddle the drugs in exchange for more bottles of the syrup, NCB sources said.The NCB probe has revealed that drugs are being diverted for illicit sale which are later abused by slum children in pockets such as Govandi, Kurla and Dharavi. The source of such diversion can be traced to Himachal Pradesh, the probe revealed.

The agency stated that over-the-counter sale in medical shops without prescription can be dangerous and further fuel the habit among drug abusers. NCB stated that the said syrup “WELCYREX” contains codeine phosphate which is the reason it is being abused. The agency has now launched a full-fledged probe to detect bulk supply chains or source of such codeine-based cough syrups.

As per the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS) provisions, codeine phosphate commercial quantity is 1000 gram. Illegal diversion of neuro-psychotropic drugs is a punishable offence under NDPS Act. Earlier this month, action was initiated after NCB intercepted two persons namely Siraj Ahmed and Mohamed Saddam from Dharavi, and seized 23.9 kgs of Codeine based cough syrup.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states